270 related articles for article (PubMed ID: 24827427)
21. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
[TBL] [Abstract][Full Text] [Related]
22. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Hansen LK
Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
[TBL] [Abstract][Full Text] [Related]
23. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.
Valverde P; Kawai T; Taubman MA
J Dent Res; 2005 Jun; 84(6):488-99. PubMed ID: 15914584
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.
Ghanshani S; Wulff H; Miller MJ; Rohm H; Neben A; Gutman GA; Cahalan MD; Chandy KG
J Biol Chem; 2000 Nov; 275(47):37137-49. PubMed ID: 10961988
[TBL] [Abstract][Full Text] [Related]
25. Th1/Th2/Th17/Treg expression in cultured PBMCs with antiphospholipid antibodies.
Xiao J; Zhu F; Liu X; Xiong J
Mol Med Rep; 2012 Nov; 6(5):1035-9. PubMed ID: 22941119
[TBL] [Abstract][Full Text] [Related]
26. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
Wulff H; Calabresi PA; Allie R; Yun S; Pennington M; Beeton C; Chandy KG
J Clin Invest; 2003 Jun; 111(11):1703-13. PubMed ID: 12782673
[TBL] [Abstract][Full Text] [Related]
27. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.
Mark Duffy S; Berger P; Cruse G; Yang W; Bolton SJ; Bradding P
J Allergy Clin Immunol; 2004 Jul; 114(1):66-72. PubMed ID: 15241346
[TBL] [Abstract][Full Text] [Related]
28. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns.
Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
Oncotarget; 2016 Jul; 7(29):44966-44974. PubMed ID: 27329601
[TBL] [Abstract][Full Text] [Related]
29. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.
Rauer H; Pennington M; Cahalan M; Chandy KG
J Biol Chem; 1999 Jul; 274(31):21885-92. PubMed ID: 10419508
[TBL] [Abstract][Full Text] [Related]
30. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
[TBL] [Abstract][Full Text] [Related]
31. Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment?
Wang J; Xiang M
Pharmacotherapy; 2013 May; 33(5):515-28. PubMed ID: 23649812
[TBL] [Abstract][Full Text] [Related]
32. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
[TBL] [Abstract][Full Text] [Related]
33. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
[TBL] [Abstract][Full Text] [Related]
34. K
Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
[TBL] [Abstract][Full Text] [Related]
35. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
[TBL] [Abstract][Full Text] [Related]
36. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
Moreno C; Prieto P; Macías Á; Pimentel-Santillana M; de la Cruz A; Través PG; Boscá L; Valenzuela C
J Immunol; 2013 Dec; 191(12):6136-46. PubMed ID: 24249731
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
[TBL] [Abstract][Full Text] [Related]
38. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.
Tanner MR; Tajhya RB; Huq R; Gehrmann EJ; Rodarte KE; Atik MA; Norton RS; Pennington MW; Beeton C
Clin Immunol; 2017 Jul; 180():45-57. PubMed ID: 28389388
[TBL] [Abstract][Full Text] [Related]
39. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation.
Petho Z; Balajthy A; Bartok A; Bene K; Somodi S; Szilagyi O; Rajnavolgyi E; Panyi G; Varga Z
Immunol Lett; 2016 Mar; 171():60-9. PubMed ID: 26861999
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of human beta-defensins 3 and 4 on potassium channels: Evidence of diversity in beta-defensin-potassium channel interactions.
Zhao Y; Xie Z; Feng J; Li W; Cao Z; Wu Y
Peptides; 2018 Oct; 108():14-18. PubMed ID: 30121363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
